SCHEMBL6984570

SCHEMBL6984570

Nc1ccc2c(-c3cccnc3)csc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 2/20 0.50
TAB1 Q15750 2/20 0.50
AXL P30530 2/20 0.49
MEN1 O00255 1/20 0.49
PSIP1 O75475 1/20 0.49
MKNK1 Q9BUB5 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
DYRK1B Q9Y463 4/20 0.47
DYRK1A Q13627 4/20 0.46
CYP11B1 P15538 2/20 0.44
CYP19A1 P11511 1/20 0.44
CYP11B2 P19099 1/20 0.44
NTRK1 P04629 1/20 0.42
PIK3CA P42336 1/20 0.42
CYP2A6 P11509 5/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2E1 P05181 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2B6 P20813 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978941 0.89 AXL (0.59) MAP3K7TAB1AXLMEN1PSIP1
SCHEMBL6985848 0.85 DYRK1A (0.50) MAP3K7TAB1AXLMEN1PSIP1
SCHEMBL6984271 0.84 NPC1 (0.52) MAP3K7TAB1DYRK1BDYRK1ACYP11B1
SCHEMBL6981144 0.82 CYP17A1 (0.50) MAP3K7TAB1DYRK1BDYRK1ACYP11B1
SCHEMBL6985095 0.82 CYP11B1 (0.45) MAP3K7TAB1MKNK1MKNK2DYRK1B
SCHEMBL6986136 0.82 CYP11B1 (0.48) MAP3K7TAB1MEN1DYRK1BDYRK1A
Hydrochloric Acid SCHEMBL6986821 0.81 CYP17A1 (0.49) MAP3K7TAB1DYRK1BDYRK1ACYP11B1
Hydrochloric Acid SCHEMBL6985047 0.81 CYP11B1 (0.44) MAP3K7TAB1MKNK1MKNK2DYRK1B
Hydrochloric Acid SCHEMBL6984263 0.81 CYP11B1 (0.47) MAP3K7TAB1MEN1DYRK1BDYRK1A
SCHEMBL6985680 0.80 CYP19A1 (0.50) MAP3K7TAB1DYRK1BDYRK1ACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130340-A1 Novel benzothiophene derivatives DAIICHI PHARMACEUTICAL CO. LTD. 2003-07-10 US disclosed
EP-1283209-A1 NOVEL BENZOTHIOPHENE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130340-A1 Novel benzothiophene derivatives CYP17A1, CYP21A2, HSD17B1 MAP3K7 2881/4885TAB1 1682/4885AXL 4126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.